NF-κB-induced Microrna-31 Promotes Epidermal Hyperplasia by Repressing Protein Phosphatase 6 in Psoriasis
Sha Yan,Zhenyao Xu,Fangzhou Lou,Lingyun Zhang,Fang Ke,Jing Bai,Zhaoyuan Liu,Jinlin Liu,Hong Wang,Huiyuan Zhu,Yang Sun,Wei Cai,Yuanyuan Gao,Bing Su,Qun Li,Xiao Yang,Jianxiu Yu,Yuping Lai,Xue-Zhong Yu,Yan Zheng,Nan Shen,Y. Eugene Chin,Honglin Wang
DOI: https://doi.org/10.1038/ncomms8652
IF: 16.6
2015-01-01
Nature Communications
Abstract:NF-κB is constitutively activated in psoriatic epidermis. However, how activated NF-κB promotes keratinocyte hyperproliferation in psoriasis is largely unknown. Here we report that the NF-κB activation triggered by inflammatory cytokines induces the transcription of microRNA (miRNA) miR-31, one of the most dynamic miRNAs identified in the skin of psoriatic patients and mouse models. The genetic deficiency of miR-31 in keratinocytes inhibits their hyperproliferation, decreases acanthosis and reduces the disease severity in psoriasis mouse models. Furthermore, protein phosphatase 6 (ppp6c), a negative regulator that restricts the G1 to S phase progression, is diminished in human psoriatic epidermis and is directly targeted by miR-31. The inhibition of ppp6c is functionally important for miR-31-mediated biological effects. Moreover, NF-κB activation inhibits ppp6c expression directly through the induction of miR-31, and enhances keratinocyte proliferation. Thus, our data identify NF-κB-induced miR-31 and its target, ppp6c, as critical factors for the hyperproliferation of epidermis in psoriasis.